← Eichor
Study identifier: NCT06133374 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples

Condition: Papillary Thyroid Cancer  ·  Sponsor: University of Calgary

PhaseN/A
Planned participants130
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to determine whether results from a fine needle biopsy are the same as results from a larger sample that is acquired from the surgical pathology using the Thyroid GuidePx® test in patients with papillary thyroid carcinoma.

This description comes directly from the study's public registry record.

Talk to the study team

Elleine Allapitan  ·  403-220-8440  ·  elleine.allapitan@ucalgary.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Foothills Medical CentreCalgary, Alberta, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06133374